Related Experiment Videos
Oxybutynin does not affect cyclosporin blood levels
1Department of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, USA.
Therapeutic Drug Monitoring
|April 11, 2001
Summary
Cyclosporin and oxybutynin, both metabolized by cytochrome P450 3A, were studied for interactions. The study found no significant changes in cyclosporin blood levels when co-administered with oxybutynin in children.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Metabolism
Background:
- Cyclosporin is a vital immunosuppressant crucial for preventing organ transplant rejection.
- Altered cyclosporin blood levels due to drug interactions can lead to toxicity or graft rejection.
- Both cyclosporin and oxybutynin are substrates of the cytochrome P450 3A (CYP3A) enzyme system.
Observation:
- The potential for a drug interaction between cyclosporin and oxybutynin was investigated.
- This investigation focused on the shared metabolic pathway involving the CYP3A enzyme system.
Findings:
- A study involving two pediatric patients assessed the impact of oxybutynin on cyclosporin levels.
- No significant alterations in trough blood cyclosporin concentrations were observed when co-administered with oxybutynin.
Implications:
- The findings suggest a potentially lower risk of CYP3A-mediated interaction between cyclosporin and oxybutynin than previously hypothesized.
- Further research may be warranted to confirm these findings in broader pediatric populations.
- This could inform clinical practice regarding the co-prescription of these medications in children.